Nanotechnology: Intelligent Design to Treat Complex Disease

@article{Couvreur2006NanotechnologyID,
  title={Nanotechnology: Intelligent Design to Treat Complex Disease},
  author={Patrick Couvreur and Christine Vauthier},
  journal={Pharmaceutical Research},
  year={2006},
  volume={23},
  pages={1417-1450}
}
The purpose of this expert review is to discuss the impact of nanotechnology in the treatment of the major health threats including cancer, infections, metabolic diseases, autoimmune diseases, and inflammations. Indeed, during the past 30 years, the explosive growth of nanotechnology has burst into challenging innovations in pharmacology, the main input being the ability to perform temporal and spatial site-specific delivery. This has led to some marketed compounds through the last decade… 

Figures and Tables from this paper

CANCER: A NANOTECHNOLOGICAL APPROACHES
TLDR
How nanotechnology can help solve one of the most challenging and longstanding problem in medicine, which is how to eliminate cancer without harming normal body tissue is addressed.
Nanotechnology based approaches in cancer therapeutics
TLDR
This topical review aims to look at the properties and various forms of NPs and their use in anticancer treatment, recent development of the process of identifying new delivery approaches as well as progress in clinical trials with these newer approaches.
The role of nanotechnology in the treatment of viral infections
TLDR
This review presents a broad overview of the application of nanosized materials for the treatment of common viral infections as well as potential candidates to explore in order to achieve and/or improve therapeutic effects.
Multifunctional nanosystems for cancer therapy
TLDR
This chapter outlines the challenges associated with effective drug and gene delivery to tumors, and strategic approaches to augment the efficacy of anticancer agents by utilizing multifunctional nanosystems, and the importance of material safety considerations for regulatory approval.
Identifying recent trends in nanomedicine development
TLDR
An overview of the trends for nanomedicine that are developing over time as measured by examining peer review research literature and patent databases is presented.
Impact of nanoscience and nanotechnology on controlled drug delivery.
TLDR
For nanomedicines intended to aid CDD in evolving successfully from laboratories to clinics and compete globally and with perhaps an unlimited lifetime, they should also have proven safety, efficacy, acceptability and availability, which indicate that well-planned interdisciplinary approaches will be required.
REVIEW: Nanobiotechnology: Cradle for revolution in drug carrier systems.
TLDR
This review tried to focus main aspects of nanotechnology in drug carrier systems for treatment and diagnosis of various diseases such as cancer, pulmonary diseases, infectious diseases, vaccine development, diabetes mellitus and the role of nan technology on the authors' economy and its positive social impacts on their community.
Nanomedicine: novel approaches in human and veterinary therapeutics.
Progress and potential of nanomedicine to address infectious diseases of poverty
TLDR
Nanotechnology is the design, manipulation, characterization, production, and application of structures, devices, and systems at the nanometer scale range (~1–500 nm), which present unique and/or superior physicochemical properties.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 504 REFERENCES
Nanomedicines for overcoming biological barriers.
  • M. Alonso
  • Biology
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  • 2004
Nanotechnology on duty in medical applications.
TLDR
This review is focused on the potential of nanotechnology in health care and medicine, including the development of nanoparticles for diagnostic and screening purposes, the manufacture of unique drug delivery systems, antisense and gene therapy applications and the enablement of tissue engineering,including the future of nanorobot construction.
Nanoparticles in cancer therapy and diagnosis.
New technology platforms in the development of vaccines for the future.
  • R. Glück
  • Biology
    Annali di igiene : medicina preventiva e di comunita
  • 2002
Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function.
  • R. Jain
  • Biology
    Journal of controlled release : official journal of the Controlled Release Society
  • 2001
The pathway to commercialization for nanomedicine.
Development of liposomal polyene antibiotics: an historical perspective.
  • Agatha W K Ng, K. Wasan, G. Lopez-Berestein
  • Medicine, Biology
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
  • 2003
TLDR
A number of promising lipid-based AmB and Nys formulations were developed to overcome toxicities of polyene antibiotics in the 1980s and 90s.
Synthetic vaccines: the role of adjuvants in immune targeting.
TLDR
Either alone or in combination with chemotherapy, innate immune therapy using TLR ligands to stimulate the immune system may offer an alternate therapeutic approach against rapidly mutating viral infections-(HIV/AIDS), and cancers.
Progress in the delivery of therapeutic oligonucleotides: organ/cellular distribution and targeted delivery of oligonucleotides in vivo.
TLDR
The current understanding of the tissue/organ distribution and cellular uptake of ODN drugs administered parenterally or nonparenterally to intact animals is reviewed and lessons learned from antisense PS studies have broad implications for ODN therapeutics in general.
...
1
2
3
4
5
...